Hepatic Vasculopathy and Regenerative Responses of the Liver in Fatal Cases of COVID-19

Clin Gastroenterol Hepatol. 2021 Aug;19(8):1726-1729.e3. doi: 10.1016/j.cgh.2021.01.044. Epub 2021 Jan 29.

Abstract

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infects the nasopharynx and lungs and causes coronavirus disease-2019 (COVID-19). It may impact the heart, brain, kidney, and liver.1 Although functional impairment of the liver has been correlated with worse clinical outcomes, little is known about the pathophysiology of hepatic injury and repair in COVID-19.2,3 Histologic evaluation has been limited to small numbers of COVID-19 cases with no control subjects2,4 and demonstrated largely heterogeneous patterns of pathology.2,3.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Kidney Injury*
  • COVID-19*
  • Humans
  • Kidney
  • Liver
  • SARS-CoV-2